title: [Time course of neuromuscular blockade after rocuronium. A comparison between women and men].
abstract: BACKGROUND
  We studied 40 patients (20 female and 20 male) undergoing elective surgery under general anaesthesia to evaluate the effect of gender on the pharmacodynamics of rocuronium.
  
  
  METHODS
  Using electromyography (EMG) we determined the maximal neuromuscular block and time course of action of 0.45 mg/kg rocuronium (1.5 x ED95).
  
  
  RESULTS
  Age and body mass index were comparable between females and males (38 (+/- 8) vs. 37 (+/- 10) years and 24.2 (+/- 2.9) vs. 25.2 (+/- 1.7) kg/m2. However, significant differences in weight and height were found between females and males (65.7 +/- 9.3 kg vs. 77.5 +/- 5.5 kg; p < 0.01 and 178 +/- 6.8 cm vs. 164 +/- 6.7 cm; p < 0.01). Onset time was shorter in females (168 +/- 65 s vs. 211 +/- 56 s; p < 0.05). Maximal neuromuscular blockade after 0.45 mg/kg rocuronium was 94 (+/- 3) % in females and 89 (+/- 6) % in males; p < 0.01. Clinical duration was increased in females (23 +/- 5 min vs. 17 +/- 5 min; p < 0.05), while the recovery index was comparable between both groups (9 +/- 4 min in females and 9 +/- 3 min in males; n.s.).
  
  
  CONCLUSIONS
  Compared to men neuromuscular blockade after 0.45 mg/kg rocuronium was more pronounced in women. The onset time was shortened and the clinical duration increased in female patients.
authors.affiliation: Klinik für Anaesthesiologie und Intensivmedizin, Universitätskliniken des Saarlandes, Homburg/Saar.
authors.forename: T
authors.initials: T
authors.lastname: Mencke
authors.forename: S
authors.initials: S
authors.lastname: Soltész
authors.forename: U
authors.initials: U
authors.lastname: Grundmann
authors.forename: M
authors.initials: M
authors.lastname: Bauer
authors.forename: N
authors.initials: N
authors.lastname: Schlaich
authors.forename: R
authors.initials: R
authors.lastname: Larsen
authors.forename: T
authors.initials: T
authors.lastname: Fuchs-Buder
mesh_terms: D000328:Adult; D000375:Aging / Q000502:physiology; D000732:Androstanols / Q000493:pharmacokinetics; D015992:Body Mass Index; D004576:Electromyography; D005260:Female; D006801:Humans; D008297:Male; D003473:Neuromuscular Nondepolarizing Agents / Q000493:pharmacokinetics; D000077123:Rocuronium; D012727:Sex Characteristics
chemical_list: D000732:Androstanols; D003473:Neuromuscular Nondepolarizing Agents; D000077123:Rocuronium